首页 › 基金 › SATOVSKY ASSET MANAGEMENT LLC › DRTS
SATOVSKY ASSET MANAGEMENT LLC 对 DRTS 的持仓历史
ALPHA TAU MEDICAL LTD · 医疗保健
SATOVSKY ASSET MANAGEMENT LLC 在 Q3 2026 的 13F 申报中披露持有 DRTS(ALPHA TAU MEDICAL LTD)36,636 股,市值约 US$546K,约占其申报组合的 0.10%,在其申报持仓中市值排名第 36 位。 SATOVSKY ASSET MANAGEMENT LLC 最近 12 个申报季度中有 12 个季度披露了 DRTS 持仓,最早可追溯至 Q4 2023。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
SATOVSKY ASSET MANAGEMENT LLC 对 DRTS 的持仓演变
SATOVSKY ASSET MANAGEMENT LLC 于 Q4 2023 首次披露 DRTS 持仓:58,430 股(约 US$176K)。 该持仓在 Q3 2026 达到峰值 36,636 股,市值约 US$546K。 在 12 次申报中,SATOVSKY ASSET MANAGEMENT LLC 1 次增持、3 次减持、7 次保持不变。 最近一期申报(Q3 2026)显示持股 36,636 股、市值约 US$546K。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2023 | 58.43K | $175.87K | 新进 |
| Q1 2024 | 48.59K | $143.35K | 减持 |
| Q2 2024 | 53.61K | $135.62K | 增持 |
| Q3 2024 | 53.61K | $127.58K | 持有 |
| Q4 2024 | 53.61K | $166.18K | 持有 |
| Q1 2025 | 53.61K | $134.55K | 持有 |
| Q2 2025 | 53.61K | $167.25K | 持有 |
| Q3 2025 | 53.61K | $241.76K | 持有 |
| Q4 2025 | 53.61K | $265.35K | 持有 |
| Q1 2026 | 40.71K | $287.79K | 减持 |
| Q2 2026 | 36.64K | $460.88K | 减持 |
| Q3 2026 | 36.64K | $546.24K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 DRTS 与 13F 数据
DRTS(ALPHA TAU MEDICAL LTD)属于医疗保健行业。我们追踪的基金中还有 71 只申报持有 DRTS,申报仓位最大的包括:Gem Investment Advisors, LLC (US$21.4M), Pier Capital, LLC (US$10.9M), Aquamarine Financial (Cayman) Ltd (US$10.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 DRTS 的基金
- Gem Investment Advisors, LLC 1.43M 股 · $21.39M · Q3 2026
- Pier Capital, LLC 730.21K 股 · $10.89M · Q3 2026
- Aquamarine Financial (Cayman) Ltd 721.50K 股 · $10.76M · Q3 2026
- Daytona Street Capital LLC 120.84K 股 · $1.80M · Q3 2026
- Dauntless Investment Group, LLC 61.20K 股 · $769.90K · Q2 2026
- WISCONSIN CAPITAL MANAGEMENT LLC 47.00K 股 · $700.77K · Q3 2026
更多关于 SATOVSKY ASSET MANAGEMENT LLC
常见问题
How long has SATOVSKY ASSET MANAGEMENT LLC held DRTS?
SATOVSKY ASSET MANAGEMENT LLC has disclosed DRTS holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is SATOVSKY ASSET MANAGEMENT LLC's current position in DRTS?
As of Q3 2026, SATOVSKY ASSET MANAGEMENT LLC holds 36.64K shares of DRTS (ALPHA TAU MEDICAL LTD), valued at $546.24K, representing 0.10% of its reported portfolio and ranking #36.
Has SATOVSKY ASSET MANAGEMENT LLC been buying or selling DRTS?
In the latest 13F filing (Q3 2026), SATOVSKY ASSET MANAGEMENT LLC held unchanged its position in DRTS. The position peaked in Q3 2026 at 36.64K shares.
Which other funds hold DRTS?
Other major institutional holders of DRTS include Gem Investment Advisors, LLC, Pier Capital, LLC, Aquamarine Financial (Cayman) Ltd, among 71 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.